Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 29:19:1579511.
doi: 10.3389/fnins.2025.1579511. eCollection 2025.

Comparative analysis of neuroinflammatory pathways in Alzheimer's disease, Parkinson's disease, and multiple sclerosis: insights into similarities and distinctions

Affiliations
Review

Comparative analysis of neuroinflammatory pathways in Alzheimer's disease, Parkinson's disease, and multiple sclerosis: insights into similarities and distinctions

Julia Doroszkiewicz et al. Front Neurosci. .

Abstract

Neurodegenerative diseases, contributing to the significant socioeconomic burden due to aging society, are gaining increasing interest. Despite each disease having different etiologies, neuroinflammation is believed to play a crucial role in Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). In addition to the pathogenic function of inflammation in the brain there is growing evidence that immune responses are essential for neuroregeneration. This review compares and contrasts the neuroinflammatory pathways that selected neurodegenerative diseases share and have in common. In AD, tau tangles and beta-amyloid plaques cause microglia and astrocytes to become activated in an inflammatory response. Alpha-synuclein aggregation stimulate neuroinflammation in Parkinson's disease, especially in the substantia nigra. In Multiple Sclerosis an autoimmune attack on myelin is connected to inflammation via invading immune cells. Commonalities include the release of pro-inflammatory mediators like cytokines and activation of signaling pathways such as NF-κB and MAPK. Comprehending these common routes is essential for discovering early diagnostic possibilities for the diseases and possible tailored treatments. Our work underscores the potential for insights into disease mechanisms. Identifying common targets offers promise for advancing our understanding and potential future treatment approaches across these debilitating disorders.

Keywords: Alzheimer’s disease; Parkinson’s disease; multiple Sclerosis; neurodegeneration; neuroinflammation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The schematic presentation of the Blood Brain Barrier.
Figure 2
Figure 2
Schematic representation of ongoing cellular and molecular processes involved in neurodegenerative disorders, including protein aggregation, mitochondrial dysfunction, oxidative stress, neuroinflammation, and synaptic loss.

Similar articles

Cited by

References

    1. Abbott N. J. (2004). Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem. Int. 45, 545–552. doi: 10.1016/j.neuint.2003.11.006 - DOI - PubMed
    1. Abbott N. J., Patabendige A. A. K., Dolman D. E. M., Yusof S. R., Begley D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13–25. doi: 10.1016/J.NBD.2009.07.030 - DOI - PubMed
    1. Akgün K., Kretschmann N., Haase R., Proschmann U., Kitzler H. H., Reichmann H., et al. . (2019). Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS. Neurol. Neuroimmunol. Neuroinflamm. 6:555. doi: 10.1212/NXI.0000000000000555 - DOI - PMC - PubMed
    1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G. M., et al. . (2000). Inflammation and Alzheimer’s disease. Neurobiol. Aging 21:383. doi: 10.1016/S0197-4580(00)00124-X - DOI - PMC - PubMed
    1. Alves S., Churlaud G., Audrain M., Michaelsen-Preusse K., Fol R., Souchet B., et al. . (2017). Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice. Brain 140, 826–842. doi: 10.1093/BRAIN/AWW330 - DOI - PubMed

LinkOut - more resources